EZH2 and myeloproliferative disorder: Loss-of-function mutations of EZH2 reduce global H3K27me3 levels to deregulate expression of target genes, and result in the development of MDS, MDS/MPN, and T-cell acute lymphoblastic leukemia [24,86].